Advertisement

Topics

GLOBAL BOTANICAL PLANT DERIVATIVE DRUG MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $2500

00:51 EDT 9 Apr 2018 | BioPortfolio Reports

KEY FINDINGS

The Global Botanical and plantderivative drug market was estimated to be worth $ 26621 million in 2017. Due to the growing application of these drugs in several diseases, the market is expected to witness a rise in CAGR of 8.58% for the forecast years of 20182026 and is predicted to reach a worth of $53850 million by its end.

MARKET INSIGHTS

The global botanical and plantderivative drug market is segmented on the basis of types, products and therapeutic applications. The type segment of the market includes steroids, terpenes, phenols glycosides, and other types. The product segment of this market includes herbal/traditional cough, cold and allergy hay fever remedies, herbal/traditional topical analgesics, herbal/traditional digestive remedies, herbal/traditional pediatric dietary supplements, herbal/traditional dermatological, herbal/traditional tonics and herbal/traditional dietary supplements. The therapeutic applications of this market can be found in dermatology, oncology, hormone disease, CNS disorders and in other therapeutic applications.

REGIONAL INSIGHTS

Geographical segmentation of the market is done into Europe, North America, AsiaPacific and rest of world. The APAC market is expected to dominate the global scene throughout the forecast period, followed by Europe and North America. A major contribution to the APAC market comes from India, where 80% rural populations still use the indigenous systems of medicines and medical herbs. Botanical Plant derivative drug market in Europe is mainly driven by rising adoption of traditional and plantbased medicines and growing investments in RD for the field of botanical medicines, whereas superior government efforts targeted towards growing the use of botanical drugs approved by FDA and the NIH's National Institutes of Health Botanical Research Centers Program are expected to boost the North America botanical plant derivative drug market growth.


COMPETITIVE INSIGHTS

Some of the renowned companies engaged in this market are Analyticon Discovery Gmbh, Abbott Laboratories, Bayer Healthcare Llc, Bionova, Boehringer Ingelheim, BristolMyers Squibb, Dr Willmar Schwabe Gmbh Co. Kg, Cura Pharm, Eli Lilly And Company, Glenmark Pharmaceuticals Ltd, GlaxoSmithKline, Indena Viale Ortles, Medigene, Lupin Ltd, Novartis International Ag, Piramal Phytocare Ltd, Pfizer, Ranbaxy Laboratories Ltd Acquired By Sun Pharmaceuticals Ltd, Tasly Pharmaceuticals Inc and Sanofi.

Original Article: GLOBAL BOTANICAL PLANT DERIVATIVE DRUG MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "GLOBAL BOTANICAL PLANT DERIVATIVE DRUG MARKET FORECAST 20182026 [Report Updated: 15012018] Prices from USD $2500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...